ClearBridge Investments Select Strategy’s Q2 2025 Investor Letter
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. U.S.
Insider Monkey Blog
13 Best Electric Utility Stocks to Buy According to Analysts
As per the Short-Term Energy Outlook by the US Energy Information Administration dated September 9, electricity generation continues to grow rapidly this year, thanks to the increased...
12 Best Beginner Stocks to Buy According to Analysts
Stronger-than-expected corporate profits and the prospect of the US Federal Reserve cutting interest rates are the catalysts likely to push equity markets higher.
9 Most Profitable Penny Stocks to Buy Right Now
The Fed is expected to cut rates for the first time in 2025.
Jim Cramer Recently Discussed These 9 Stocks
“If you ask me, the real rocket fuel, it's the expansion of what we call the price-to-earnings multiple or what we will pay for the company's earnings.
QuantaSing Group Ltd (NASDAQ:QSG) Q4 2025 Earnings Call Transcript
Operator: Good morning and good evening, ladies and gentlemen. Thank you for standing by, and welcome to the QuantaSing's Earnings Conference Call.
General Mills, Inc. (NYSE:GIS) Q1 2026 Earnings Call Transcript
General Mills, Inc. (NYSE:GIS) Q1 2026 Earnings Call Transcript September 17, 2025General Mills, Inc. beats earnings expectations.
Innate Pharma S.A. (NASDAQ:IPHA) Q2 2025 Earnings Call Transcript
Innate Pharma S.A. (NASDAQ:IPHA) Q2 2025 Earnings Call Transcript September 17, 2025Innate Pharma S.A. beats earnings expectations.
Flux Power Holdings, Inc. (NASDAQ:FLUX) Q4 2025 Earnings Call Transcript
Flux Power Holdings, Inc. (NASDAQ:FLUX) Q4 2025 Earnings Call Transcript September 16, 2025Flux Power Holdings, Inc. beats earnings expectations.
Evolution Petroleum Corporation (AMEX:EPM) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Evolution Petroleum Fourth Quarter and Fiscal Year 2025 Earnings Conference Call.
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2026 Earnings Call Transcript
Champions Oncology, Inc. (NASDAQ:CSBR) Q1 2026 Earnings Call Transcript September 15, 2025Champions Oncology, Inc. beats earnings expectations.
Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) Q2 2025 Earnings Call Transcript
Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) Q2 2025 Earnings Call Transcript September 15, 2025Dave & Buster's Entertainment, Inc. misses on earnings expectations.
Huize Holding Limited (NASDAQ:HUIZ) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to Huize's Second Quarter 2025 Earnings Conference Call.
Jim Cramer Thinks NIKE, Inc. (NKE)’s “Not Stopping At A Hundred”
Recently, Cramer got rather sentimental about NIKE, Inc. (NYSE:NKE).
Eaton Corporation (ETN): Analysts Call It a “Secular Winner” Amid AI Boom
Eaton Corporation plc (NYSE:ETN) is one of the AI Stocks You Should Not Ignore. On September 15, Melius upgraded the stock to “Buy” from Neutral with a price target of $495...
Wedbush Bullish on Palo Alto Networks (PANW), Calls CyberArk Acquisition a “Game Changer”
Palo Alto Networks, Inc.
Deutsche Bank Bullish on Micron (MU) Ahead of Earnings, Sees Strong AI-Driven Demand
Micron Technology, Inc.
Broadcom (AVGO) Initiated as Outperform With $420 Price Target Amid AI Growth
Broadcom Inc. (NASDAQ:AVGO) is one of the AI Stocks You Should Not Ignore. On September 15, Macquarie initiated the stock with an Outperform rating and $420 price target.
Oppenheimer Names NVIDIA (NVDA) a Top AI Pick Amid Long-Term Structural Growth
NVIDIA Corporation (NASDAQ:NVDA) is one of the AI Stocks You Should Not Ignore. One of the biggest analyst calls on Monday, September 15, was for Nvidia.
10 Big Names Investors Are Dumping
Meanwhile, the Dow Jones was the sole gainer among all Wall Street indices, up 0.57 percent.
All-Time Rush: 8 of 10 Big Names Hit Fresh Record Highs
Ten big names stood out during the trading session on Wednesday—eight of which propelled to new all-time highs—on the back of company-specific catalysts buoying investing ...
CleanSpark (CLSK) Jumps 8.8% as US Starts Work on 1-Million Bitcoin Purchase
CleanSpark extended its winning streak to a fifth consecutive day on Tuesday, jumping 8.84 percent to finish at $11.20 apiece as investors loaded portfolios in crypto mining and...
Jim Cramer Says Some People Are “Afraid” To Take Up NVIDIA Corporation (NVDA)
NVIDIA Corporation (NASDAQ:NVDA) is one of the most frequently discussed stocks by Jim Cramer, which is unsurprising given that it is the most valuable company in the world and...
Analysts Say Talen Energy (TLN) Guidance Is ‘Clearly Conservative’
On September 11, Barclays analyst Nicholas Campanella raised the firm’s price target on the stock to $440 from $418 and kept an “Overweight” rating on the shares following...
Arista Networks (ANET): Analysts Eye $140 Price Target Amid AI Growth
Arista Networks Inc (NYSE:ANET) is one of the AI Stocks Analysts Say You Should Watch Closely. On September 12, Rosenblatt analyst Mike Genovese raised the price target on the...
What Does Wall Street Think About Rigel Pharmaceuticals (RIGL)?
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is one of the best affordable biotech stocks to invest in now. Rigel Pharmaceuticals, Inc.
What Do Analysts Think About Puma Biotechnology (PBYI)?
Puma Biotechnology, Inc. (NASDAQ:PBYI) is one of the best affordable biotech stocks to invest in now. Puma Biotechnology, Inc.
Where is Innoviva (INVA) Headed According to Analysts?
Innoviva, Inc. (NASDAQ:INVA) is one of the best affordable biotech stocks to invest in now. On August 11, H.C.
Where is Halozyme Therapeutics (HALO) Headed According to Analysts?
Halozyme Therapeutics, Inc.
Zevra Therapeutics (ZVRA) Announces Positive New Data Supporting Foundational Role of MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) is one of the best affordable biotech stocks to invest in now. On September 4, Zevra Therapeutics, Inc.
Bernstein Reiterates a Sell Rating on Genmab A/S (GMAB)
Genmab A/S (NASDAQ:GMAB) is one of the best affordable biotech stocks to invest in now. In a report released on September 8, Justin Smith from Bernstein reiterated a Sell rating...
UBS Maintains a Buy Rating on Harmony Biosciences Holdings (HRMY), Sets a $50 PT
Harmony Biosciences Holdings, Inc.
Wall Street Bullish on Barclays PLC (BCS), Since Q2 Results
Barclays PLC (NYSE:BCS) is one of the Best Performing Financial Stocks So Far in 2025.
Bank of America Securities Raises PT on UBS Group AG (UBS), Keeps a Hold
UBS Group AG (NYSE:UBS) is one of the Best Performing Financial Stocks So Far in 2025.
TD Cowen Maintains a Buy on Royalty Pharma (RPRX)
Royalty Pharma Plc (NASDAQ:RPRX) is one of the best affordable biotech stocks to invest in now. On September 12, TD Cowen analyst Michael Nedelcovych maintained a Buy rating ...
The Bank of New York Mellon (BK) Partners with Carnegie Mellon University to Advance AI Research
The Bank of New York Mellon Corporation (NYSE:BK) is one of the Best Performing Financial Stocks So Far in 2025.
Bank of America Securities Maintains a Buy Rating on Incyte Corporation (INCY), Sets a $104 PT
Incyte Corporation (NASDAQ:INCY) is one of the best affordable biotech stocks to invest in now. In a report released on September 15, Tazeen Ahmad from Bank of America Securities...
Morgan Stanley Maintains a Hold Rating on Goldman Sachs Group (GS)
The Goldman Sachs Group, Inc. (NYSE:GS) is one of the Best Performing Financial Stocks So Far in 2025.
BMO Capital Reiterates a Buy on BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best affordable biotech stocks to invest in now.
Cantor Fitzgerald Raises the Firm’s PT on Robinhood Markets (HOOD), Keeps a Buy
Robinhood Markets, Inc. (NASDAQ:HOOD) is one of the Best Performing Financial Stocks So Far in 2025.
Regeneron Pharmaceuticals (REGN) Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron Pharmaceuticals, Inc.
Citi Reiterates a Buy Rating on Nu Holdings (NU), Keeps the PT
Nu Holdings Ltd. (NYSE:NU) is one of the Best Performing Financial Stocks So Far in 2025.
Hedge Fund Resource Center
